Document is current
Any future updates will be listed below
-
Authors
Klockgether, Thomas
Grobe-Einsler, Marcus
Faber, Jennifer
-
Funding
Funding for this research was provided by:
Deutsches Zentrum für Neurodegenerative Erkrankungen e.V. (DZNE) in der Helmholtz-Gemeinschaft
- License Information
-
More Information
Article History
Accepted: 15 May 2025
First Online: 24 May 2025
Declarations
:
: Not applicable.
: T. Klockgether is receiving research support from the Bundesministerium für Bildung und Forschung (BMBF), Servier, and UCB. Within the last 24 months, he has received consulting fees from Arrowhead, Bristol-Myers Squibb, and UCB. M. Grobe-Einsler is receiving research support from the Bundesministerium für Bildung und Forschung (BMBF), National Ataxia Foundation (NAF), and Ataxia UK. Within the last 24 months, he has received consulting fees from Healthcare Manufacture Germany and Biogen. J. Faber is receiving research support from the Bundesministerium für Bildung und Forschung (BMBF), the National Ataxia Foundation (NAF), Servier, and UCB. Within the last 24 months, she has received consulting fees from Vico Therapeutics.
